CHBAF(CHBAF)
CHBAF
No analyst ratings available
No analyst price targets available for CHBAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $262.48B | $344.76B | $370.35B | $273.13B |
| Low | $262.22B | $318.61B | $355.05B | $261.84B |
| High | $270.13B | $388.33B | $400.54B | $295.40B |
| EBITDA Avg | $97.25B | $127.73B | $137.21B | $101.19B |
| Low | $97.15B | $118.04B | $131.54B | $97.01B |
| High | $100.08B | $143.87B | $148.40B | $109.44B |
| EBIT Avg | $88.09B | $115.70B | $124.29B | $91.66B |
| Low | $88.00B | $106.92B | $119.15B | $87.87B |
| High | $90.65B | $130.32B | $134.42B | $99.14B |
| Net Income Avg | $716M | $847M | $875M | $866M |
| Low | $677M | $802M | $828M | $820M |
| High | $792M | $937M | $968M | $958M |
| EPS Avg | $161.64 | $191.31 | $197.63 | $195.56 |
| Low | $152.95 | $181.03 | $187.01 | $185.06 |
| High | $178.77 | $211.59 | $218.58 | $216.29 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $66.60B | $65.23B | $66.47B | $74.82B | $81.47B | $80.87B | $83.41B | $88.72B |
| Low | $65.69B | $64.35B | $65.57B | $73.80B | $80.37B | $79.78B | $82.28B | $87.51B |
| High | $67.50B | $66.11B | $67.37B | $75.83B | $82.58B | $81.97B | $84.54B | $89.92B |
| EBITDA Avg | $24.67B | $24.17B | $24.63B | $27.72B | $30.19B | $29.96B | $30.90B | $32.87B |
| Low | $24.34B | $23.84B | $24.29B | $27.34B | $29.78B | $29.56B | $30.48B | $32.42B |
| High | $25.01B | $24.50B | $24.96B | $28.10B | $30.59B | $30.37B | $31.32B | $33.31B |
| EBIT Avg | $22.35B | $21.89B | $22.31B | $25.11B | $27.34B | $27.14B | $27.99B | $29.77B |
| Low | $22.05B | $21.59B | $22.00B | $24.77B | $26.97B | $26.77B | $27.61B | $29.37B |
| High | $22.65B | $22.19B | $22.61B | $25.45B | $27.71B | $27.51B | $28.37B | $30.18B |
| Net Income Avg | $29.25B | $28.64B | $29.42B | $30.65B | $34.35B | $33.15B | $35.04B | $36.71B |
| Low | $28.73B | $28.13B | $28.90B | $30.11B | $33.75B | $32.57B | $34.43B | $36.07B |
| High | $29.76B | $29.14B | $29.94B | $31.19B | $34.96B | $33.73B | $35.66B | $37.36B |
| EPS Avg | $41.88 | $41.00 | $42.12 | $43.88 | $49.19 | $47.47 | $50.18 | $52.57 |
| Low | $41.14 | $40.28 | $41.38 | $43.11 | $48.32 | $46.63 | $49.29 | $51.64 |
| High | $42.62 | $41.73 | $42.86 | $44.66 | $50.05 | $48.30 | $51.06 | $53.50 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |